Tag Archive for: elafibranor

Ipsen, Genfit’s elafibranor wins FDA approval for primary biliary cholangitis

Ipsen and Genfit’s elafibranor will now be marketed as Iqirvo and is the first new medicine approved in nearly a decade for the treatment of the rare liver disease, according to the companies.

Read more
/by

Ipsen, Genfit build case for rare liver disease drug with Phase III data

,

In a late-stage trial, treatment with Ipsen and Genfit’s elafibranor led to high rates of biochemical response and the normalization of alkaline phosphatase levels compared with placebo.

Read more
/by